11:14 AM EDT, 03/19/2026 (MT Newswires) -- Globant ( GLOB ) and PharmaMar said Thursday that they established a multi-agent artificial intelligence system for cancer research under their collaboration.

The companies said the system was built through Globant Enterprise AI and is designed to maintain accuracy in complex data retrieval and accelerate delivery of insights in oncology research.

The system features more than 20 specialized digital agents across preclinical, clinical, regulatory, commercial and strategy areas of cancer drug discovery, the partners added.

No financial terms were disclosed.

Price: 45.24, Change: +0.97, Percent Change: +2.19